BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32940665)

  • 1. Alteration of fecal microbiota by fucoxanthin results in prevention of colorectal cancer in AOM/DSS mice.
    Terasaki M; Uehara O; Ogasa S; Sano T; Kubota A; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
    Carcinogenesis; 2021 Feb; 42(2):210-219. PubMed ID: 32940665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
    Burgueño JF; Fritsch J; González EE; Landau KS; Santander AM; Fernández I; Hazime H; Davies JM; Santaolalla R; Phillips MC; Diaz S; Dheer R; Brito N; Pignac-Kobinger J; Fernández E; Conner GE; Abreu MT
    Gastroenterology; 2021 Feb; 160(3):797-808.e6. PubMed ID: 33127391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emu oil and grape seed extract reduce tumour burden and disease parameters in murine colitis-associated colorectal cancer.
    Chartier LC; Howarth GS; Trinder D; Mashtoub S
    Carcinogenesis; 2021 Feb; 42(2):202-209. PubMed ID: 32940671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of C-C chemokine receptor 1 is a key regulation for colon cancer chemoprevention in AOM/DSS mice by fucoxanthin.
    Terasaki M; Ono S; Hashimoto S; Kubota A; Kojima H; Ohta T; Tanaka T; Maeda H; Miyashita K; Mutoh M
    J Nutr Biochem; 2022 Jan; 99():108871. PubMed ID: 34571188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Biscuit Containing Fucoxanthin Prevents Colorectal Carcinogenesis in Mice.
    Terasaki M; Murase W; Kamakura Y; Kawakami S; Kubota A; Kojima H; Ohta T; Tanaka T; Maeda H; Miyashita K; Mutoh M
    Nutr Cancer; 2022; 74(10):3651-3661. PubMed ID: 35695489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuity of Tumor Microenvironmental Suppression in AOM/DSS Mice by Fucoxanthin May Be Able to Track With Salivary Glycine.
    Terasaki M; Kimura R; Kubota A; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
    In Vivo; 2020; 34(6):3205-3215. PubMed ID: 33144425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota.
    Wang C; Li W; Wang H; Ma Y; Zhao X; Zhang X; Yang H; Qian J; Li J
    BMC Microbiol; 2019 Nov; 19(1):246. PubMed ID: 31694526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice.
    Wang Q; Wang K; Wu W; Lv L; Bian X; Yang L; Wang Q; Li Y; Ye J; Fang D; Wu J; Jiang X; Xie J; Lu Y; Li L
    Appl Microbiol Biotechnol; 2020 Jul; 104(13):5915-5928. PubMed ID: 32367312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fucoxanthin potentiates anoikis in colon mucosa and prevents carcinogenesis in AOM/DSS model mice.
    Terasaki M; Iida T; Kikuchi F; Tamura K; Endo T; Kuramitsu Y; Tanaka T; Maeda H; Miyashita K; Mutoh M
    J Nutr Biochem; 2019 Feb; 64():198-205. PubMed ID: 30530259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects.
    Zhao R; Coker OO; Wu J; Zhou Y; Zhao L; Nakatsu G; Bian X; Wei H; Chan AWH; Sung JJY; Chan FKL; El-Omar E; Yu J
    Gastroenterology; 2020 Sep; 159(3):969-983.e4. PubMed ID: 32387495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary Fucoxanthin Induces Anoikis in Colorectal Adenocarcinoma by Suppressing Integrin Signaling in a Murine Colorectal Cancer Model.
    Terasaki M; Ikuta M; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31905803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhein modulates host purine metabolism in intestine through gut microbiota and ameliorates experimental colitis.
    Wu J; Wei Z; Cheng P; Qian C; Xu F; Yang Y; Wang A; Chen W; Sun Z; Lu Y
    Theranostics; 2020; 10(23):10665-10679. PubMed ID: 32929373
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis.
    Petito V; Graziani C; Lopetuso LR; Fossati M; Battaglia A; Arena V; Scannone D; Quaranta G; Quagliariello A; Del Chierico F; Putignani L; Masucci L; Sanguinetti M; Sgambato A; Gasbarrini A; Scaldaferri F
    World J Gastroenterol; 2019 Mar; 25(12):1465-1477. PubMed ID: 30948910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoxanthin Alleviates Dextran Sulfate Sodium-Induced Colitis and Gut Microbiota Dysbiosis in Mice.
    Yang YH; Chen C; Zheng Y; Wu ZJ; Zhou MQ; Liu XY; Miyashita K; Duan DL; Du L
    J Agric Food Chem; 2024 Feb; 72(8):4142-4154. PubMed ID: 38355398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice.
    Liu M; Xie W; Wan X; Deng T
    Int Immunopharmacol; 2020 Nov; 88():106862. PubMed ID: 32771947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juglone regulates gut microbiota and Th17/Treg balance in DSS-induced ulcerative colitis.
    Hua Y; Liu R; Lu M; Guan X; Zhuang S; Tian Y; Zhang Z; Cui L
    Int Immunopharmacol; 2021 Aug; 97():107683. PubMed ID: 33915494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.
    Tian Z; Liu J; Liao M; Li W; Zou J; Han X; Kuang M; Shen W; Li H
    Dig Dis Sci; 2016 Aug; 61(8):2262-2271. PubMed ID: 26846120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fucoxanthin Prevents Colorectal Cancer Development in Dextran Sodium Sulfate-treated
    Terasaki M; Hamoya T; Kubota A; Kojima H; Tanaka T; Maeda H; Miyashita K; Mutoh M
    Anticancer Res; 2021 Mar; 41(3):1299-1305. PubMed ID: 33788721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Effect of Proteinase-Activated Receptor-1 Antagonist on Colitis-Associated Carcinogenesis.
    Li X; Kurahara LH; Zhao Z; Zhao F; Ishikawa R; Ohmichi K; Li G; Yamashita T; Hashimoto T; Hirano M; Sun Z; Hirano K
    Cell Mol Gastroenterol Hepatol; 2024; 18(1):105-131. PubMed ID: 38614455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics suppress colon tumorigenesis through inhibition of aberrant DNA methylation in an azoxymethane and dextran sulfate sodium colitis model.
    Hattori N; Niwa T; Ishida T; Kobayashi K; Imai T; Mori A; Kimura K; Mori T; Asami Y; Ushijima T
    Cancer Sci; 2019 Jan; 110(1):147-156. PubMed ID: 30443963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.